info
Google Groups no longer supports new Usenet posts or subscriptions. Historical content remains viewable.
Dismiss
F.D.A. Advisory Panel Recommends Pfizer Boosters for Older People and Others at High Risk (NYTimes)
27 views
Skip to first unread message
VegasJerry
Sep 17, 2021, 8:27:11 PM9/17/21
to
F.D.A. Advisory Panel Recommends Pfizer Boosters for Older People and Others at High Risk (NYTimes)
The committee said there was insufficient evidence to
recommend third shots for all adult recipients of the
vaccine, as Pfizer had requested.
WASHINGTON — A key advisory panel to the Food and Drug Administration overwhelmingly rejected recommending Pfizer booster shots for most recipients of the company’s coronavirus vaccine, instead endorsing them only for people who are 65 or older or at high risk of severe Covid-19, and received their second dose at least six months ago.
The vote — the first on boosters in the United States — was a blow to the Biden administration’s strategy to make extra shots available to most fully vaccinated adults in the United States eight months after they received a second dose. The broader rollout was to start next week.
Committee members appeared dismissive of the argument that the general population needed booster shots, saying the data from Pfizer and elsewhere still seemed to show two shots protected against severe disease or hospitalization and did not prove a third shot would stem the spread of infection. Some also criticized a lack of data that an additional injection would be safe for younger people.
“It’s unclear that everyone needs to be boosted, other than a subset of the population that clearly would be at high risk for serious disease,” said Dr. Michael G. Kurilla, a committee member and official at the National Institutes of Health.
https://www.nytimes.com/2021/09/17/us/fda-pfizer-booster-covid.html?unlocked_article_code=AAAAAAAAAAAAAAAACEIPuonUktbfqohkQVUaBCbIRp8pohTDnfbO0rEmw3X5KzOJRCwHxOMLAoTG-1vIYeArQeoP6AmhZY0LNq4zFrs1x_VDPkdpRk70rJaJlMQOe2Bq84i9Gz481cuIDL5moXrjZWSyIrsun-a0tRvMeCK9DvykpH4lIAxkqJRmcEj7miBbg_eYTZMmn4V2zvwjBZhlRDcfZCjsvvDgCBl2PNzufQiLo0BtGLkfAWeP6Ibav7EQcwxSCUbFTWd94gs-6dBcPNAQPMXvPkMUWXqYeA4hvlxoRfmldmg&smid=url-share
https://tinyurl.com/m3phrz7k
The committee said there was insufficient evidence to
recommend third shots for all adult recipients of the
vaccine, as Pfizer had requested.
WASHINGTON — A key advisory panel to the Food and Drug Administration overwhelmingly rejected recommending Pfizer booster shots for most recipients of the company’s coronavirus vaccine, instead endorsing them only for people who are 65 or older or at high risk of severe Covid-19, and received their second dose at least six months ago.
The vote — the first on boosters in the United States — was a blow to the Biden administration’s strategy to make extra shots available to most fully vaccinated adults in the United States eight months after they received a second dose. The broader rollout was to start next week.
Committee members appeared dismissive of the argument that the general population needed booster shots, saying the data from Pfizer and elsewhere still seemed to show two shots protected against severe disease or hospitalization and did not prove a third shot would stem the spread of infection. Some also criticized a lack of data that an additional injection would be safe for younger people.
“It’s unclear that everyone needs to be boosted, other than a subset of the population that clearly would be at high risk for serious disease,” said Dr. Michael G. Kurilla, a committee member and official at the National Institutes of Health.
https://www.nytimes.com/2021/09/17/us/fda-pfizer-booster-covid.html?unlocked_article_code=AAAAAAAAAAAAAAAACEIPuonUktbfqohkQVUaBCbIRp8pohTDnfbO0rEmw3X5KzOJRCwHxOMLAoTG-1vIYeArQeoP6AmhZY0LNq4zFrs1x_VDPkdpRk70rJaJlMQOe2Bq84i9Gz481cuIDL5moXrjZWSyIrsun-a0tRvMeCK9DvykpH4lIAxkqJRmcEj7miBbg_eYTZMmn4V2zvwjBZhlRDcfZCjsvvDgCBl2PNzufQiLo0BtGLkfAWeP6Ibav7EQcwxSCUbFTWd94gs-6dBcPNAQPMXvPkMUWXqYeA4hvlxoRfmldmg&smid=url-share
https://tinyurl.com/m3phrz7k
Pierre Trudeau
Sep 17, 2021, 8:37:01 PM9/17/21
to
risky biz
Sep 17, 2021, 9:02:05 PM9/17/21
to
Meanwhile:
'U.S. to buy hundreds of millions more doses of Pfizer vaccine to donate to the world'
The Washington Post
VegasJerry
Sep 18, 2021, 11:13:29 AM9/18/21
to
On Friday, September 17, 2021 at 5:37:01 PM UTC-7, Pierre Trudeau wrote:
It’s the FDA (Food & Drug) ADVISORY panel. ADVISORY (you DO know what than means, righ?). They voted on the: ”Safety and effectiveness data,” being, “… (D)o they known the potential benefits,” (that means, yea, the booster does in fact give you additional protection - benefit), “outweigh the known and potential risks?” (Undefined) from a clinical trial, support boosters after 6 months for those 16 and older. i.e. Should everybody over 16 get a booster shot? The vote was 16-2 against.
Oh, and some argued, “There shouldn’t be booster shots because they would do more good (meaning they do help) going to countries that haven’t any.” AGAIN, they DO help.
On Question #2: “How about a booster for those 65 and older or at high risk?” They voted 18-0, YES.
Huh? So how did they reach a 16-2 against for everybody? (Hello?) The risk data for the young is not in. The benefits are.
THEN that very same FDA Advisory Panel – ADVISORY panel – scratched it’s pointed heads and said, (not in answer to a question #3) “Uh, and yea, maybe also healthcare workers?; teachers, nurse?; and, uh, and others at high-risk occupational exposure?” (Hello? Again, why not in the original vote?) So what’s the fractured vote for that (or ‘those?’)
The ACTUAL FDA decision (this is just the ADVISORY panel, remember) comes next week. And, no, they do not have to take the ADVISE(S) of the ADVISORY panel.
Also next week the CDC (Center for DISEASE Control – you know, like Disease SCIENTISTS?) Advisory panel meets next week, too. Let’s see what they say – about the PROVEN benefits of booster shots.
Now wipe the shit off your chin and run away..
(JFC, some people’s kids……….)
0 new messages